Jeryl L. Hilleman

Insider Reports History

Location
Menlo Park, CA
Signature
/s/ Nathan Salha, as Attorney-in-Fact for Jeryl L. Hilleman
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jeryl L. Hilleman:

Form 4 holding Director

NovoCure Ltd

Security class
Stock Option (Right to Buy)
Shares / value
16,697
Estimated value
$101,533
Report date
04 Jun 2025
Price
$16.30
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
Form 4 holding Director

CUTERA INC

Security class
Stock Option (Right to Buy)
Shares / value
40,000
Estimated value
Report date
24 Oct 2024
Price
Ownership
Direct
Underlying class
COMMON STOCK
Underlying amount
Form 4 holding Director

HilleVax, Inc.

Security class
Stock Option
Shares / value
22,500
Estimated value
Report date
06 Jun 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Minerva Neurosciences, Inc.

Security class
Stock Option (right to buy)
Shares / value
12,500
Estimated value
Report date
27 Sep 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

NovoCure Ltd

Security class
Restricted Stock Units
Shares / value
6,590
Estimated value
Report date
05 Jun 2024
Price
Ownership
Direct

Insider Reports Filed by Jeryl L. Hilleman

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .